Liver International · 2012 · 38 citations · 14 references
MedicinePreventive MedicineEarly DetectionEpidemiologic MethodsHepatologyBiomarkers Of Liver InjuryChronic Liver DiseaseHepatic Function TestingHepatic ImpairmentLiver DiseaseLiver Function TestsChronic Liver Disease EvaluationInterpretation Of Liver Function TestsLiver Disease Risk AssessmentLiver Enzyme AbnormalitiesLiver Function Test Reference RangesLiver Function Test SpecificitySerum Alanine AminotransferaseThresholds
BACKGROUND/AIMS: Serum alanine aminotransferase (ALT) is an easily available, low-cost screening tool for detecting silent chronic liver disease. Recent studies have suggested that the currently accepted healthy ALT thresholds be lowered. METHODS: In this retrospective cross-sectional study, we determined upper thresholds for ALT values in a nationally representative healthy cohort (n = 3337) from the Fourth Korea National Health and Nutrition Examination Survey (KNHANES IV). Sensitivity and specificity of the currently used ALT threshold (40 IU/L, regardless of gender) was compared against study-derived, gender-specific ALT thresholds for detecting individuals at risk for chronic liver disease in 27 913 health check-up participants. RESULTS: The 95th percentile levels for ALT in healthy weight, metabolically normal, liver disease-free KNHANES participants were 34 IU/L for men and 25 IU/L for women. The prevalence of ALT elevation among health check-up participants was 11.0% in currently used thresholds, and increased to 22.6% with study-derived, gender-specific thresholds. Of the population who were additionally defined to have elevated ALT levels under new ALT threshold, 65.7% were at risk for chronic liver disease. Sensitivity for detecting individuals at risk for chronic liver disease improved from 18 to 33% with new thresholds whereas a trade-off in specificity (from 96 to 88%) was observed. CONCLUSIONS: It is recommendable to lower the current ALT thresholds to better identify individuals at risk for chronic liver disease.
14
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
Marc G. Ghany, Doris B. Strader, David L. Thomas et al. · Hepatology · 2008 · 3K citations · Full text
Chronic hepatitis B: Update 2009 #
Anna S. Lok, Brian J. McMahon · Hepatology · 2009 · 2.8K citations · Full text
The Metabolic Syndrome as a Predictor of Nonalcoholic Fatty Liver Disease
Masahide Hamaguchi, Takao Kojima, Noriyuki Takeda et al. · Annals of Internal Medicine · 2005 · 1.1K citations
Ultrasound scanning in the detection of hepatic fibrosis and steatosis.
S.H. Saverymuttu, A.E.A. Joseph, J. D. Maxwell · BMJ · 1986 · 850 citations · Full text